The new insulin medicine will be sold with Civica’s branding across the US except for Californa where it will be sold under CalRx brand. Civica will also handle all US sales, promotion, and distribution, according to the announcement.
The new insulin medicine will be sold with Civica’s branding across the US except for Californa where it will be sold under CalRx brand. Civica will also handle all US sales, promotion, and distribution, according to the announcement.